160 results
8-K
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
27 Dec 23
Completion of Acquisition or Disposition of Assets
8:25pm
affirmatively determined that Mr. Cross qualifies as an “independent director” under the applicable rules and regulations of The Nasdaq Stock Market
425
4no55xrd r6j9
18 Dec 23
Business combination disclosure
6:02am
8-K
9pasc za27ushro59
18 Dec 23
Other Events
6:01am
424B3
dxxd5y5 nj3w5mnzzj
21 Nov 23
Prospectus supplement
9:15am
S-4/A
dfsghbpu8md uo
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4/A
EX-23.3
04pflh8 6o3
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4/A
EX-23.2
b10jp o029
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4
70xh6nxz2t0q xt
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
S-4
EX-23.3
eb85w
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
S-4
EX-23.2
n8uroud8o8 aovk
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
8-K
EX-4.1
mcua4
20 Oct 23
Unregistered Sales of Equity Securities
2:19pm
425
EX-2.1
5bi drsewnm
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
8nb4a55g
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
wsa5ay0ydldm8017ukn1
21 Aug 23
Departure of Directors or Certain Officers
8:00am
8-K
EX-4.1
2quiw23f56a8xt
3 Aug 23
Unregistered Sales of Equity Securities
4:03pm